Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on May 21, 2025
Synfini Inc. and Multispan Announce Drug Discovery Collaboration
GlobeNewswire
·
May 21, 2025
MENLO PARK, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., the leader in AI-driven agile chemistry for better molecule discovery, announced today that it has entered a collaboration with biotechnology company Multispan to co-discover and develop …
WORK Medical Technology Group LTD Announces Pricing of Registered Offering
GlobeNewswire
·
May 21, 2025
Hangzhou, China, May 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and …
Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission
GlobeNewswire
·
May 21, 2025
PHM23 was one of a handful of molecules chosen by the university Bird Flu helping PHM23 gain awareness of broad-spectrum activity at a university level BOSTON, MASSACHUSETTS, May 21, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a …
Carestream Launches Carestream 360º: A New Analytics Dashboard for Streamlined Reporting and Deeper Operational Insight
GlobeNewswire
·
May 21, 2025
Rochester, N.Y., May 21, 2025 (GLOBE NEWSWIRE) -- Carestream Health today announced the U.S. market launch of Carestream 360º, an advanced analytics dashboard designed to help radiology departments track key performance metrics, analyze imaging trends, and …
Youth Vaping Rates Plummet: Canadian Vaping Association Urges Shift to Adult Harm Reduction Strategies
GlobeNewswire
·
May 21, 2025
Ottawa, ON, May 21, 2025 (GLOBE NEWSWIRE) -- Statistics Canada’s latest findings from the 2025 Canadian Health Survey on Children and Youth reveal a dramatic decline in youth vaping, with past 30-day use among Canadians aged 12–17 dropping to 7.2%, a near …
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
GlobeNewswire
·
May 21, 2025
SARASOTA, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into a …
Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung Cancer
GlobeNewswire
·
May 21, 2025
GRAND CAYMAN, Cayman Islands, May 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced …
Latin America Advanced Wound Care Market worth US$498.2 million by 2030 with 9.8% CAGR | MarketsandMarkets™.
GlobeNewswire
·
May 21, 2025
Delray Beach, FL, May 21, 2025 (GLOBE NEWSWIRE) -- The global latin america advanced wound care market, valued at US$285.9 million in 2024, is forecasted to grow at a robust CAGR of 9.8%, reaching US$312.8 million in 2025 and an impressive US$498.2 million …
ABLi Therapeutics Announces Details of the End of Phase 2 Meeting with FDA for Evaluation of Risvodetinib as a Treatment for Parkinson’s Disease
GlobeNewswire
·
May 21, 2025
Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa initiation as an endpoint to measure trial success, which Company believes is a direct measure of …
BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025
GlobeNewswire
·
May 21, 2025
SUNNYVALE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that BioCardia’s CEO, Peter Altman, Ph.D., …
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance
GlobeNewswire
·
May 21, 2025
Conduit regains compliance with Bid Price and Equity Requirements CDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) …
Paratek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
GlobeNewswire
·
May 21, 2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercialization of specialty therapies for specialists and community care providers, that address important …
Proto Hologram Inventor named to TIME100 Health List
GlobeNewswire
·
May 21, 2025
New York, New York, May 21, 2025 (GLOBE NEWSWIRE) -- TIME has named David Nussbaum, Founder and Chairman of Proto Inc., to its 2025 TIME100 Health list in the "Innovators" category, recognizing his pioneering work creating hologram and AI technology to …
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025
GlobeNewswire
·
May 21, 2025
WALTHAM, Mass., May 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network
GlobeNewswire
·
May 21, 2025
FORT MYERS, Fla., May 21, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it is expanding access to cutting-edge radioligand therapies (RLT), providing more patients …
Soleno Therapeutics to Participate in Upcoming June Conferences
GlobeNewswire
·
May 21, 2025
REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the …
Alignment Healthcare to Present at William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 21, 2025
ORANGE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, at 2 p.m. CDT. A webcast and replay of the …
Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025
GlobeNewswire
·
May 21, 2025
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane protein function, today announced that it will present a …
Konica Minolta Healthcare to Launch Integrated Teleradiology Solution Powered by NewVue
GlobeNewswire
·
May 21, 2025
TAMPA, Fla. and WAYNE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a pioneer in imaging and healthcare IT innovation, and NewVue, the leading provider of intelligent, cloud-native radiology workflow solutions, today …
Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101
GlobeNewswire
·
May 21, 2025
Represents significant milestone in the development of KAD101, a novel biologic prolactin receptor antagonist, being initially developed for the treatment of platinum resistant ovarian cancer (PROC) with expansion opportunities into endometrial, uterine …